Literature DB >> 26796672

Transforming Growth Factor-β: Master Regulator of the Respiratory System in Health and Disease.

Yael Aschner1, Gregory P Downey1,2,3,4,5.   

Abstract

In this article, we review the biology and physiological importance of transforming growth factor-β (TGF-β) to homeostasis in the respiratory system, its importance to innate and adaptive immune responses in the lung, and its pathophysiological role in various chronic pulmonary diseases including pulmonary arterial hypertension, chronic obstructive pulmonary disease, asthma, and pulmonary fibrosis. The TGF-β family is responsible for initiation of the intracellular signaling pathways that direct numerous cellular activities including proliferation, differentiation, extracellular matrix synthesis, and apoptosis. When TGF-β signaling is dysregulated or essential control mechanisms are unbalanced, the consequences of organ and tissue dysfunction can be profound. The complexities and myriad checkpoints built into the TGF-β signaling pathways provide attractive targets for the treatment of these disease states, many of which are currently being investigated. This review focuses on those aspects of TGF-β biology that are most relevant to pulmonary diseases and that hold promise as novel therapeutic targets.

Entities:  

Keywords:  COPD; asthma; fibroblast; pulmonary arterial hypertension; pulmonary fibrosis

Mesh:

Substances:

Year:  2016        PMID: 26796672      PMCID: PMC4942197          DOI: 10.1165/rcmb.2015-0391TR

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  95 in total

1.  PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling.

Authors:  Xia Lin; Xueyan Duan; Yao-Yun Liang; Ying Su; Katharine H Wrighton; Jianyin Long; Min Hu; Candi M Davis; Jinrong Wang; F Charles Brunicardi; Yigong Shi; Ye-Guang Chen; Anming Meng; Xin-Hua Feng
Journal:  Cell       Date:  2006-06-02       Impact factor: 41.582

2.  Integrin-mediated type II TGF-β receptor tyrosine dephosphorylation controls SMAD-dependent profibrotic signaling.

Authors:  Xiwu Chen; Hongtao Wang; Hong-Jun Liao; Wen Hu; Leslie Gewin; Glenda Mernaugh; Sheng Zhang; Zhong-Yin Zhang; Lorenzo Vega-Montoto; Roberto M Vanacore; Reinhard Fässler; Roy Zent; Ambra Pozzi
Journal:  J Clin Invest       Date:  2014-07-01       Impact factor: 14.808

3.  Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease (COPD).

Authors:  H Takizawa; M Tanaka; K Takami; T Ohtoshi; K Ito; M Satoh; Y Okada; F Yamasawa; K Nakahara; A Umeda
Journal:  Am J Respir Crit Care Med       Date:  2001-05       Impact factor: 21.405

4.  Altered expression of small proteoglycans, collagen, and transforming growth factor-beta 1 in developing bleomycin-induced pulmonary fibrosis in rats.

Authors:  G Westergren-Thorsson; J Hernnäs; B Särnstrand; A Oldberg; D Heinegård; A Malmström
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

Review 5.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

6.  Thrombospondin-1 is a major activator of TGF-beta1 in vivo.

Authors:  S E Crawford; V Stellmach; J E Murphy-Ullrich; S M Ribeiro; J Lawler; R O Hynes; G P Boivin; N Bouck
Journal:  Cell       Date:  1998-06-26       Impact factor: 41.582

7.  Pulmonary hypertension in transgenic mice expressing a dominant-negative BMPRII gene in smooth muscle.

Authors:  James West; Karen Fagan; Wolfgang Steudel; Brian Fouty; Kirk Lane; Julie Harral; Marloes Hoedt-Miller; Yuji Tada; John Ozimek; Rubin Tuder; David M Rodman
Journal:  Circ Res       Date:  2004-03-18       Impact factor: 17.367

8.  Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity.

Authors:  Gareth J Inman; Francisco J Nicolás; Caroline S Hill
Journal:  Mol Cell       Date:  2002-08       Impact factor: 17.970

9.  Abnormal lung development and cleft palate in mice lacking TGF-beta 3 indicates defects of epithelial-mesenchymal interaction.

Authors:  V Kaartinen; J W Voncken; C Shuler; D Warburton; D Bu; N Heisterkamp; J Groffen
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

10.  Fibrotic myofibroblasts manifest genome-wide derangements of translational control.

Authors:  Ola Larsson; Deanna Diebold; Danhua Fan; Mark Peterson; Richard Seonghun Nho; Peter B Bitterman; Craig A Henke
Journal:  PLoS One       Date:  2008-09-16       Impact factor: 3.240

View more
  79 in total

Review 1.  Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets.

Authors:  Justin C Hewlett; Jonathan A Kropski; Timothy S Blackwell
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

Review 2.  The role of genetics in pulmonary arterial hypertension.

Authors:  Lijiang Ma; Wendy K Chung
Journal:  J Pathol       Date:  2016-11-29       Impact factor: 7.996

Review 3.  Building and Regenerating the Lung Cell by Cell.

Authors:  Jeffrey A Whitsett; Tanya V Kalin; Yan Xu; Vladimir V Kalinichenko
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

Review 4.  New therapeutics based on emerging concepts in pulmonary fibrosis.

Authors:  Vishwaraj Sontake; Prathibha R Gajjala; Rajesh K Kasam; Satish K Madala
Journal:  Expert Opin Ther Targets       Date:  2018-11-28       Impact factor: 6.902

5.  Protein tyrosine phosphatase-α amplifies transforming growth factor-β-dependent profibrotic signaling in lung fibroblasts.

Authors:  Yael Aschner; Meghan Nelson; Matthew Brenner; Helen Roybal; Keriann Beke; Carly Meador; Daniel Foster; Kelly A Correll; Paul R Reynolds; Kelsey Anderson; Elizabeth F Redente; Jennifer Matsuda; David W H Riches; Steve D Groshong; Ambra Pozzi; Jan Sap; Qin Wang; Dhaarmini Rajshankar; Christopher A G McCulloch; Rachel L Zemans; Gregory P Downey
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-06-03       Impact factor: 5.464

6.  Subacute TGFβ Exposure Drives Airway Hyperresponsiveness in Cystic Fibrosis Mice through the PI3K Pathway.

Authors:  Elizabeth L Kramer; Satish K Madala; Kristin M Hudock; Cynthia Davidson; John P Clancy
Journal:  Am J Respir Cell Mol Biol       Date:  2020-05       Impact factor: 6.914

7.  Transforming Growth Factor-β1 Increases DNA Methyltransferase 1 and 3a Expression through Distinct Post-transcriptional Mechanisms in Lung Fibroblasts.

Authors:  Hailey B Koh; Anne M Scruggs; Steven K Huang
Journal:  J Biol Chem       Date:  2016-07-12       Impact factor: 5.157

8.  Variation in doses and duration of particulate matter exposure in bronchial epithelial cells results in upregulation of different genes associated with airway disorders.

Authors:  Priya Tripathi; Furong Deng; Anne M Scruggs; Yahong Chen; Steven K Huang
Journal:  Toxicol In Vitro       Date:  2018-05-09       Impact factor: 3.500

9.  Tissue Factor Facilitates Wound Healing in Human Airway Epithelial Cells.

Authors:  Michael D Davis; Isao Suzaki; Shuichi Kawano; Kosaku Komiya; Qing Cai; Youngman Oh; Bruce K Rubin
Journal:  Chest       Date:  2018-10-22       Impact factor: 9.410

Review 10.  Flexor Tendon: Development, Healing, Adhesion Formation, and Contributing Growth Factors.

Authors:  Ashley L Titan; Deshka S Foster; James Chang; Michael T Longaker
Journal:  Plast Reconstr Surg       Date:  2019-10       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.